Renan is the Movies & TV Lead Editor for GameRant. Ren graduated Cum Laude from Lesley University in 2017 and has been focusing exclusively on his journalistic endeavors ever since. When Ren isn't ...

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Agent workflows make transport a first-order ...

Semaglutide is part of a group of medicines called GLP-1 receptor agonists, commonly used to manage type 2 diabetes. In recent years, it has also gained worldwide attention for helping with weight ...

Senate Republicans have for weeks been debating the use of the “talking filibuster” to guarantee the passage of the SAVE America Act in the upper chamber, after President Donald Trump called the ...

For most products, “Made in the USA” is a point of pride. For medicine, it may be about safety. After months of investigating drug manufacturing overseas, we found something rare — a company still ...

After delivering solid sales growth in a difficult 2025, Germany’s Merck KGaA may have a tougher go of things this year, which the company is crediting in part to a predicted onslaught of U.S.

Merck KGaA forecast lackluster earnings in guidance that reflects generic competition for its multiple sclerosis blockbuster drug Mavenclad, but not the potential benefits from the US launch of a ...

Resident Evil Requiem has a complicated story, though that shouldn’t come as a surprise to anyone who has kept up with the series over 30 years. Capcom’s survival horror games are filled with evil ...

What is the meaning of Reanimal's ending? The ending to Reanimal's story is largely up to interpretation, but there is fun to be had trawling through all the theories out there. The story toys with ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...